Dianthus Therapeutics, Inc. /DE/ Balance Sheet
DNTH / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
Dianthus Therapeutics, Inc. /DE/ had $531M in total assets and $493M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51.1M | $22.8M | $132.3M | $15.4M | $131.7M | $58.2M | $65.1M | $58.3M | $51.4M | - |
| Accounts Receivable | $52.0K | $807.0K | $294.0K | $4.7M | - | - | - | - | - | - |
| Current Assets | $409.4M | $280.9M | $177.5M | $82.0M | $180.7M | $151.5M | $149.8M | $145.3M | $52.5M | - |
| PP&E (Net) | $296.0K | $194.0K | $185.0K | $142.0K | $7.5M | $8.3M | $9.9M | $10.2M | $2.0M | - |
| Total Assets | $530.9M | $374.0M | $179.4M | $83.1M | $189.9M | $161.6M | $161.5M | $157.3M | $54.5M | - |
| Current Liabilities | $30.7M | $18.5M | $9.6M | $8.2M | $10.9M | $11.4M | $14.1M | $10.4M | $4.1M | - |
| Shareholders' Equity | $493.4M | $352.5M | $168.9M | -$44.4M | -$17.2M | $143.9M | $141.2M | $145.6M | -$42.1M | -$8.9M |